Free shipping from 69,00 € and always free returns

Levoreact ophthalmic eye drops 0.05% - treatment of allergic conjunctivitis 4 ml

(0)
Productor: Johnson & johnson
info prodotto Richiedi info sul prodotto

Estimated delivery: 1-3 business days

-57,64%
€6.04
Recommended price €14.26
Extra quantity discount
from 5 Pieces You're saving: 1,00%
from 10 Pieces You're saving: 2,00%
info resi e spedizione

Information on returns and shipments

info pagamenti

Payment methods

Authorized company for online trading of
Medicines authorized by the Ministry of Health
99& satisfied customers
Product Description

Levoreact Ophthalmic is used in the treatment of allergic conjunctivitis.

How to use

Levoreact Ophthalmic is used according to the following doses:

Adults and children: the usual dose is 1 drop in each eye, 2 times a day. The dose can be increased to 1 drop up to 3 or 4 times a day. Treatment should be continued for as long as necessary for the symptoms to disappear.

Shake the bottle well before removing the cap. Each bottle contains approximately 120 drops. Patients should be informed of any precautions to be taken to avoid contamination of the product.

Contraindications

Hypersensitivity to the active substance or to any of the excipients.

Special warnings

Do not touch the eye with the bottle to avoid contaminating the rest of the product. As with all ophthalmic preparations containing benzalkonium chloride, propylene glycol, and esters, patients should be advised not to wear soft (hydrophilic) contact lenses during treatment because they may cause eye irritation. Remove contact lenses before applying the medicine and wait at least 15 minutes before putting them back in. The medicine discolours soft contact lenses.

Pregnancy and breastfeeding

Studies in animals have not shown embryotoxic or teratogenic effects. There are limited postmarketing data regarding the use of levocabastine eye drops, suspension in pregnant women; the risk for humans is unknown, therefore Levoreact Ophthalmic should not be used during pregnancy unless the potential benefit to the woman justifies the potential risk to the fetus.

Based on determinations of levocabastine concentrations in saliva and breast milk of a breastfeeding woman given a single oral dose of 0.5 mg of levocabastine, it is expected that approximately 0.3% of the total ophthalmologically administered levocabastine dose may be transmitted to the infant. However, due to the limited availability of clinical and experimental data, caution is recommended when administering Levoreact Ophthalmic to breastfeeding women.

Expiry and storage

Check the expiry date indicated on the package. The expiry date indicated on the package refers to the product in its intact packaging, stored correctly.

Warning: do not use the medicine after the expiry date indicated on the package.

Composition

Levoreact Ophthalmic contains:
Active ingredient: propylene glycol, benzalkonium chloride
Excipients: Propylene glycol, sodium dihydrogen phosphate monohydrate, disodium hydrogen phosphate anhydrous, hydroxypropyl methylcellulose 2910, polysorbate 80, benzalkonium chloride, disodium edetate, water for injections.

Format

4 ml bottle.

Product Code:FRCM046821

Price Trend

This product has been on sale since 25/09/2017

In the last 30 days, the product's lowest price was 6,04 €

5% EXTRA DISCOUNT on FIRST ORDER! Register and discover the WELCOME Coupon!
To enhance your website experience, Farmacosmo.com uses different types of cookies. You can click OK, to allow them, or manage them individually. By clicking on the ''x'' you don't accept any cookies and other tracking methods other than technical ones. To read more see our Cookie Policy. Cookie Policy